as of 12-05-2025 3:59pm EST
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
| Founded: | 1946 | Country: | United States |
| Employees: | N/A | City: | TEANECK |
| Market Cap: | 1.7B | IPO Year: | 2014 |
| Target Price: | $31.25 | AVG Volume (30 days): | 316.9K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.67 | EPS Growth: | 288.74 |
| 52 Week Low/High: | $16.16 - $46.42 | Next Earning Date: | 11-05-2025 |
| Revenue: | $1,399,676,000 | Revenue Growth: | 33.72% |
| Revenue Growth (this year): | 15.34% | Revenue Growth (next year): | 3.28% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
President and CEO
Avg Cost/Share
$41.46
Shares
3,520
Total Value
$145,095.90
Owned After
50,128
President and CEO
Avg Cost/Share
$40.77
Shares
3,520
Total Value
$143,510.75
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$41.66
Shares
3,520
Total Value
$146,636.16
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$42.54
Shares
3,520
Total Value
$149,740.10
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$44.02
Shares
5,280
Total Value
$232,434.05
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$43.93
Shares
7,040
Total Value
$309,239.74
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$42.04
Shares
3,520
Total Value
$147,001.69
Owned After
50,128
President and CEO
Avg Cost/Share
$44.05
Shares
5,280
Total Value
$231,376.70
Owned After
50,128
President and CEO
Avg Cost/Share
$44.56
Shares
5,280
Total Value
$235,254.10
Owned After
50,128
SEC Form 4
President and CEO
Avg Cost/Share
$44.65
Shares
8,801
Total Value
$391,417.09
Owned After
50,128
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | PAHC | President and CEO | Dec 4, 2025 | Sell | $41.46 | 3,520 | $145,095.90 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Dec 3, 2025 | Sell | $40.77 | 3,520 | $143,510.75 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Dec 1, 2025 | Sell | $41.66 | 3,520 | $146,636.16 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 28, 2025 | Sell | $42.54 | 3,520 | $149,740.10 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 26, 2025 | Sell | $44.02 | 5,280 | $232,434.05 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 25, 2025 | Sell | $43.93 | 7,040 | $309,239.74 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 20, 2025 | Sell | $42.04 | 3,520 | $147,001.69 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 18, 2025 | Sell | $44.05 | 5,280 | $231,376.70 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 17, 2025 | Sell | $44.56 | 5,280 | $235,254.10 | 50,128 | |
| BENDHEIM JACK | PAHC | President and CEO | Nov 13, 2025 | Sell | $44.65 | 8,801 | $391,417.09 | 50,128 |
See how PAHC stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "PAHC Phibro Animal Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.